Stewart GD - Search Results

1

NO-sulindac inhibits the hypoxia response of PC-3 prostate cancer cells via the Akt signalling pathway.

Stewart GD, Nanda J, Brown DJ, Riddick AC, Ross JA, Habib FK. Stewart GD, et al. Int J Cancer. 2009 Jan 1;124(1):223-32. doi: 10.1002/ijc.23934. Int J Cancer. 2009. PMID: 18924134

2

Results of a definitive study are needed to provide guidance on the treatment of patients with screen-detected, 'low-grade' prostate cancer.

Stewart GD, Riddick AC, Bollina PR, McNeill SA. Stewart GD, et al. BJU Int. 2006 Nov;98(5):944-5. doi: 10.1111/j.1464-410X.2006.06540.x. BJU Int. 2006. PMID: 17034595 No abstract available.

3

Dermcidin expression confers a survival advantage in prostate cancer cells subjected to oxidative stress or hypoxia.

Stewart GD, Lowrie AG, Riddick AC, Fearon KC, Habib FK, Ross JA. Stewart GD, et al. Prostate. 2007 Sep 1;67(12):1308-17. doi: 10.1002/pros.20618. Prostate. 2007. PMID: 17626247

4

Is there a human homologue to the murine proteolysis-inducing factor?

Wieland BM, Stewart GD, Skipworth RJ, Sangster K, Fearon KC, Ross JA, Reiman TJ, Easaw J, Mourtzakis M, Kumar V, Pak BJ, Calder K, Filippatos G, Kremastinos DT, Palcic M, Baracos VE. Wieland BM, et al. Among authors: stewart gd. Clin Cancer Res. 2007 Sep 1;13(17):4984-92. doi: 10.1158/1078-0432.CCR-07-0946. Clin Cancer Res. 2007. PMID: 17785548

5

The dermcidin gene in cancer: role in cachexia, carcinogenesis and tumour cell survival.

Stewart GD, Skipworth RJ, Ross JA, Fearon KCh, Baracos VE. Stewart GD, et al. Curr Opin Clin Nutr Metab Care. 2008 May;11(3):208-13. doi: 10.1097/MCO.0b013e3282fb7b8d. Curr Opin Clin Nutr Metab Care. 2008. PMID: 18403914 Review.

6

Re: androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response.

Stewart GD, Habib FK. Stewart GD, et al. Eur Urol. 2008 May;53(5):1085. doi: 10.1016/j.eururo.2008.02.009. Eur Urol. 2008. PMID: 18485321 No abstract available.

7

Analysis of hypoxia-associated gene expression in prostate cancer: lysyl oxidase and glucose transporter-1 expression correlate with Gleason score.

Stewart GD, Gray K, Pennington CJ, Edwards DR, Riddick AC, Ross JA, Habib FK. Stewart GD, et al. Oncol Rep. 2008 Dec;20(6):1561-7. Oncol Rep. 2008. PMID: 19020742

8

The relevance of a hypoxic tumour microenvironment in prostate cancer.

Stewart GD, Ross JA, McLaren DB, Parker CC, Habib FK, Riddick AC. Stewart GD, et al. BJU Int. 2010 Jan;105(1):8-13. doi: 10.1111/j.1464-410X.2009.08921.x. Epub 2009 Nov 4. BJU Int. 2010. PMID: 19889065 Review.

9

Mass spectrometric detection of candidate protein biomarkers of cancer cachexia in human urine.

Skipworth RJ, Stewart GD, Bhana M, Christie J, Sturgeon CM, Guttridge DC, Cronshaw AD, Fearon KC, Ross JA. Skipworth RJ, et al. Among authors: stewart gd. Int J Oncol. 2010 Apr;36(4):973-82. doi: 10.3892/ijo_00000577. Int J Oncol. 2010. PMID: 20198343

10

DNA strand breaks and hypoxia response inhibition mediate the radiosensitisation effect of nitric oxide donors on prostate cancer under varying oxygen conditions.

Stewart GD, Nanda J, Katz E, Bowman KJ, Christie JG, Brown DJ, McLaren DB, Riddick AC, Ross JA, Jones GD, Habib FK. Stewart GD, et al. Biochem Pharmacol. 2011 Jan 15;81(2):203-10. doi: 10.1016/j.bcp.2010.09.022. Epub 2010 Oct 1. Biochem Pharmacol. 2011. PMID: 20888325

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters